Dr. Nassin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S. MARYLAND AVE.
M/C 2040
Chicago, IL 60637Phone+1 773-702-6808Fax+1 773-702-0414
Education & Training
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
- Rush Medical College of Rush University Medical CenterClass of 2010
Certifications & Licensure
- UT State Medical License 2023 - 2026
- IL State Medical License 2013 - 2023
- MA State Medical License Active through 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease Start of enrollment: 2020 Apr 07
Publications & Presentations
PubMed
- 7 citationsEfficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.Ami V Desai, Mark A Applebaum, Theodore G Karrison, Akosua Oppong, Cindy Yuan
Cancer. 2022-08-01 - 3 citationsThe addition of autologous stem cell transplantation to neoadjuvant chemotherapy, radiation, and HIPEC for patients with unresectable desmoplastic small round cell tum...Amir Siddiqui, Navin Pinto, Mark A Applebaum, Grace Z Mak, John M Cunningham
International Journal of Surgery. Oncology. 2020-12-01 - 11 citationsImmune Reconstitution Following Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma at the Time of ImmunotherapyMichele L. Nassin, Elitsa V. Nicolaou, Sandeep Gurbuxani, Susan L. Cohn, John M. Cunningham
Biology of Blood and Marrow Transplantation. 2017-12-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: